ARCHIVES

Phase III Regorafenib Trial Meets PFS Primary Endpoint

This article is from The Cancer Letter archive.

Vol. 35 No. 6 | June 29, 2012

Download PDF Visit The Full Archive

Related Articles

12 Minority CCOPs Awardees Names, San Antonio Gets 2

September 21, 1990

In Brief: More Money For Fewer Grants? Or Spread It Around, Rhoads Asks; AACR To Take Stands

June 10, 1977

Simone Retires From Academic Medicine, But Plans To Remain Active In Advisory Roles.

September 7, 2001

Study Finds No Link Between Tumor Grade and Relapse Risk

February 25, 2011

Beta Blockers Negate Harmful Recurrence Risks of ACE Inhibitors

April 29, 2011

NCCS Selects New President

October 9, 2009